Analisis Kuantitatif Expected Return dan Standar Deviasi (Kasus SIDO dan KLBF)

Authors

  • Dian Evelyn Naibaho Trisakti School Of Management
  • Amelia Nurhatta Trisakti School of Management
  • Neysa Adellia Trisakti School Of Management
  • Salwa Safitri Humairoh Trisakti School Of Management

DOI:

https://doi.org/10.69718/ijesm.v3i1.395

Keywords:

Expected Return, Standard Deviation, Markowitz Model, pharmaceutical stocks, investment risk

Abstract

This study analyzes the efficient performance of pharmaceutical stocks listed in the LQ45 index, specifically PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) and PT Kalbe Farma Tbk (KLBF.JK), using the Markowitz Model. Data collected from 2020 to 2024 reveals distinct characteristics in expected return and investment risk between the two stocks. SIDO recorded an expected return of 0.0090 (0.9%) with a standard deviation of 0.0887 (8.87%), indicating higher return potential but accompanied by greater risk. Conversely, KLBF showed an expected return of 0.0044 (0.4%) and a standard deviation of 0.0509 (5.09%), suggesting lower risk but also lower return potential.

The findings highlight that SIDO is an efficient choice for risk-seeking investors willing to tolerate higher volatility for greater returns. Meanwhile, KLBF is more suitable for risk-averse investors prioritizing stability. This study emphasizes the importance of understanding the relationship between expected return and risk in investment decision-making and provides insights into the application of the Markowitz Model in evaluating portfolio efficiency.

Author Biographies

Dian Evelyn Naibaho, Trisakti School Of Management

This study analyzes the efficient performance of pharmaceutical stocks listed in the LQ45 index, specifically PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) and PT Kalbe Farma Tbk (KLBF.JK), using the Markowitz Model. Data collected from 2020 to 2024 reveals distinct characteristics in expected return and investment risk between the two stocks. SIDO recorded an expected return of 0.0090 (0.9%) with a standard deviation of 0.0887 (8.87%), indicating higher return potential but accompanied by greater risk. Conversely, KLBF showed an expected return of 0.0044 (0.4%) and a standard deviation of 0.0509 (5.09%), suggesting lower risk but also lower return potential.The findings highlight that SIDO is an efficient choice for risk-seeking investors willing to tolerate higher volatility for greater returns. Meanwhile, KLBF is more suitable for risk-averse investors prioritizing stability. This study emphasizes the importance of understanding the relationship between expected return and risk in investment decision-making and provides insights into the application of the Markowitz Model in evaluating portfolio efficiency.

Neysa Adellia, Trisakti School Of Management

This study analyzes the efficient performance of pharmaceutical stocks listed in the LQ45 index, specifically PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) and PT Kalbe Farma Tbk (KLBF.JK), using the Markowitz Model. Data collected from 2020 to 2024 reveals distinct characteristics in expected return and investment risk between the two stocks. SIDO recorded an expected return of 0.0090 (0.9%) with a standard deviation of 0.0887 (8.87%), indicating higher return potential but accompanied by greater risk. Conversely, KLBF showed an expected return of 0.0044 (0.4%) and a standard deviation of 0.0509 (5.09%), suggesting lower risk but also lower return potential.The findings highlight that SIDO is an efficient choice for risk-seeking investors willing to tolerate higher volatility for greater returns. Meanwhile, KLBF is more suitable for risk-averse investors prioritizing stability. This study emphasizes the importance of understanding the relationship between expected return and risk in investment decision-making and provides insights into the application of the Markowitz Model in evaluating portfolio efficiency.

Salwa Safitri Humairoh, Trisakti School Of Management

This study analyzes the efficient performance of pharmaceutical stocks listed in the LQ45 index, specifically PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) and PT Kalbe Farma Tbk (KLBF.JK), using the Markowitz Model. Data collected from 2020 to 2024 reveals distinct characteristics in expected return and investment risk between the two stocks. SIDO recorded an expected return of 0.0090 (0.9%) with a standard deviation of 0.0887 (8.87%), indicating higher return potential but accompanied by greater risk. Conversely, KLBF showed an expected return of 0.0044 (0.4%) and a standard deviation of 0.0509 (5.09%), suggesting lower risk but also lower return potential.The findings highlight that SIDO is an efficient choice for risk-seeking investors willing to tolerate higher volatility for greater returns. Meanwhile, KLBF is more suitable for risk-averse investors prioritizing stability. This study emphasizes the importance of understanding the relationship between expected return and risk in investment decision-making and provides insights into the application of the Markowitz Model in evaluating portfolio efficiency.

References

Ayuninsih, A. A. (t.thn.). Lontara Journal of Mathematics, Statistics And Application Perhitungan Expected Return dan Risiko untuk Menentukan Portofolio Efisien pada Perusahaan Keuangan di Bursa Efek Indonesia Menggunakan Model Markowitz.

Ginting, S. (2013). ANALISIS FAKTOR-FALTOR YANG MEMPENGARUHI RETURN SAHAM PADA PERUSAHAAN MANUFAKTUR YANG TERDAFTAR DI BURSA EFEK INDONESIA.

Herdiansyah H, R. (2023, 11 2). ANALISIS KINERJA KEUANGAN TERHADAP RETURN SAHAM PADA PERUSAHAAN SUB SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA 2018-2021. JURNAL PUNDI, 151.

Hidayat, F. J. (2016). ANALISIS KINERJA SAHAM SEKTOR FARMASI PADA BURSA EFEK INDONESIA (BEI) TAHUN 2012-2014. Jurnal Riset Akuntansi dan Keuangan.

Setiawan1, A. (t.thn.). ANALISIS KINERJA SAHAM PADA INDUSTRI FARMASI SEBELUM DAN SETELAH ADANYA PANDEMI COVID-19. 10.

Sujarweni, V. W. (2014). Metodologi Penelitian Lengkap, praktis, dan mudah dipahami .

Takarini, N. (2023). Analisis Rasio Keuangan terhadap Harga Saham pada Perusahaan Farmasi yang Terdaftar di Bursa Efek Indonesia. Ekonomis: Journal of Economics and Business, 234.

Takarini, N. D. (2023). Analisis Rasio Keuangan terhadap Harga Saham pada Perusahaan Farmasi yang Terdaftar di Bursa Efek Indonesia. Ekonomis: Journal of Economics and Business.

Downloads

Published

2025-03-31

How to Cite

Dian Evelyn Naibaho, Nurhatta, A., Neysa Adellia, & Salwa Safitri Humairoh. (2025). Analisis Kuantitatif Expected Return dan Standar Deviasi (Kasus SIDO dan KLBF). IJESM Indonesian Journal of Economics and Strategic Management, 3(1). https://doi.org/10.69718/ijesm.v3i1.395

Issue

Vol. 3 No. 1 (2025): March

Section

Articles

License

Copyright (c) 2025 IJESM Indonesian Journal of Economics and Strategic Management

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.